Heart failure patients surviving longerMcKnight’s Long Term Care NewsMortality rates have declined for patients with advanced heart failure during the past two decades, according to new research from UCLA. Still, a third of patients do not survive more…
|
Screening Using Peptide Level and Collaborative Care to Help Reduce Risk of …
Newswise (press release) Newswise — Among patients at risk of heart failure, collaborative care based on screening for certain levels of brain-type natriuretic peptide reduced the combined rates of left ventricular systolic dysfunction, diastolic dysfunction, and heart … |
Screening using peptide level and collaborative care to help reduce risk of …EurekAlert (press release)Among patients at risk of heart failure, collaborative care based on screening for certain levels of brain-type natriuretic peptide reduced the com…
Toronto NewsFIX |
Improving survival in heart failure
Toronto NewsFIX Heart failure is the leading cause of hospitalization for those over 65. It causes breathlessness, fatigue and swelling of the legs – and often results from pre-existing heart problems. As the population ages, the incidence of heart failure is bound to … |
|
New Tool for assessing the Prognosis of Chronic Heart Failure Patients …
Labmate Online Abbott has announced CE marking for the ARCHITECT® Galectin-3 assay, a test to aid doctors in assessing the prognosis of patients diagnosed with chronic heart failure (HF). The test was developed in partnership with BG Medicine, Inc to run on Abbott’s … |
|
Mount Sinai becomes first NYC medical center to use new HeartMate II …
News-Medical.net The Mount Sinai Medical Center is the first medical center in New York City to offer the newly FDA approved HeartMate II® Pocket Controller™ to help its advanced heart failure patients maintain more active lifestyles. This latest generation controller … |
Heart Failure: Mobbing James GandolfiniHuffington PostHeart Failure: Mobbing James Gandolfini. Posted: 06/28/2013 5:21 pm. Follow. Crime, GPS For The Soul, James Gandolfini, Arts And Culture, Entertainment, Healthy Living, Heart Health, Huff/post50, Te…
Medical Daily |
Baby Aspirin Recall: Acetaminophen Mix-Up Could Lead To Overdose, Liver …
Medical Daily “That could put some people into liver failure,” said Dr. Joe Odin of Mount Sinai hospital in New York. Acetaminophen, commonly sold as Tylenol, is a pain reliever and fever reducer. It is used to treat headache, muscles aches, arthritis, and colds … Aspirin Recalled Over Acetaminophen Mix-UpABC News Baby Aspirin Recalled After Acetaminophen DiscoveryWebMD Mix-Up Leads To Nationwide Aspirin Recall13WHAM-TV NewsChannel 9 WSYR –msnNOW –The Inquisitr all 11 news articles » |
|
GlobalData: Upcoming Novartis chronic heart failure drug expected to dominate …
PharmaLive (press release) (subscription) Research and consulting firm GlobalData has released a new report, PharmaPoint: Chronic Heart Failure – Global Drug Forecast and Market Analysis to 2022 and forecasts global sales of Novartis’ combination drug LCZ-696 to reach a massive $1.86 billion … |
|
GlobalData Expects New Novartis Heart Failure Drug to Reach $1.9 Billion …
PharmaLive (press release) (subscription) LONDON, UK (GlobalData), 20 June 2013 – Following a launch scheduled for 2015 for the treatment of Chronic Heart Failure (CHF), Novartis’ novel combination drug LCZ-696 will rapidly dominate the global CHF therapeutics sector and mark a drug … |